A Longitudinal Study of Point Prevalence of Antimicrobial Use and Resistance in Ahvaz Hospitals in 2020 - 2021: A Multicenter Study
Jundishapur Journal of Microbiology · 07.01.2025 · 18 (1)
DOI: 10.5812/jjm-146724 ↗Kurz gefasst
Fachartikel in der Zeitschrift Jundishapur Journal of Microbiology, online erschienen am 07.01.2025. Verfasst von Ahmad Shamsizadeh und 7 weiteren Autor:innen. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Excessive prescription of antibiotics is the main factor contributing to the emergence of resistant bacteria.
Objectives
To complement the global research conducted by Belgium's Antrop University and the World Health Organization (WHO) in Iran, this study aimed to evaluate the prevalence of antibiotic prescriptions in Ahvaz hospitals.
Methods
This was a descriptive longitudinal study. The statistical population consisted of all patients hospitalized at Imam Khomeini, Golestan, and Abuzar Hospitals in Ahvaz between 2020 and 2021 (2035 patients). The data collection tool was a checklist from the educational department and special care department, completed by clinical assistants and recorded in the Global Point Prevalence online software. Data analysis was performed using SPSS version 22.
Results
The overall prevalence of antimicrobial use in Golestan, Imam Khomeini, and Abuzar Hospitals was reported as 43.2%, 44.1%, and 57.9%, respectively. The most common antibiotics for treating sepsis in both adults and children were vancomycin and meropenem. The most commonly used antibiotics for treating upper and lower urinary tract infections (UTIs) and for surgical prophylaxis were ceftriaxone and meropenem. Meropenem was the most commonly used antibiotic for treating pneumonia. The highest rates of antimicrobial resistance were reported for cefazolin (81.42%), ampicillin (93.77%), and ampicillin (94.02%) in Golestan, Imam Khomeini, and Abuzar Hospitals, respectively. The lowest rates of antimicrobial resistance were reported for ciprofloxacin (18.57%) in Golestan Hospital, ciprofloxacin (15.58%) in Imam Khomeini Hospital, and piperacillin/tazobactam (12.04%) in Abuzar Hospital.
Conclusions
Due to the high consumption of ceftriaxone and the significant resistance to ampicillin and cefazolin, continuous monitoring is essential to adjust antibiotic usage and resistance patterns in local, provincial, and national referral hospitals.
Zitieren
APA
Shamsizadeh, A., Assar, S., Soltani, J., Aramesh, M. R., Fathi, M. R., Shakournia, F., Pakmehr, M., & Ghaedamini, H. (2025). A Longitudinal Study of Point Prevalence of Antimicrobial Use and Resistance in Ahvaz Hospitals in 2020 - 2021: A Multicenter Study. Jundishapur Journal of Microbiology, 18(1). https://doi.org/10.5812/jjm-146724
Vancouver
Shamsizadeh A, Assar S, Soltani J, Aramesh MR, Fathi MR, Shakournia F, et al. A Longitudinal Study of Point Prevalence of Antimicrobial Use and Resistance in Ahvaz Hospitals in 2020 - 2021: A Multicenter Study. Jundishapur Journal of Microbiology. 2025;18(1). doi:10.5812/jjm-146724
BibTeX
@article{Shamsizadeh2025,
author = {Shamsizadeh, Ahmad and Assar, Shideh and Soltani, Jafar and Aramesh, Mohammad Reza and Fathi, Mohammad Reza and Shakournia, Fereshteh and Pakmehr, Mostafa and Ghaedamini, Hossein},
title = {A Longitudinal Study of Point Prevalence of Antimicrobial Use and Resistance in Ahvaz Hospitals in 2020 - 2021: A Multicenter Study},
journal = {Jundishapur Journal of Microbiology},
year = {2025},
volume = {18},
number = {1},
doi = {10.5812/jjm-146724}
}
EUVIMED